Manufacturer: Boehringer Ingelheim
Trajenta contains the active substance linagliptin which belongs to a group of medicines known as ‘oral antidiabetics’. Oral antidiabetics are used to treat high blood sugar levels. They work by helping the body lower the level of sugar in your blood.
Trajenta is used to treat ‘type 2 diabetes’ in adults, if the disease cannot be adequately controlled with an oral antidiabetic medicine (metformin or sulphonylureas) or diet and exercise alone. Trajenta can be used together with other antidiabetic medicines, eg. eg, metformin, sulfonylureas (eg, glimepiride, glipizide), empagliflozin, or insulin.